Lyrica

Lyrica

pregabalin

Manufacturer:

Viatris

Distributor:

Zuellig Pharma
Concise Prescribing Info
Contents
Pregabalin
Indications/Uses
Central & peripheral neuropathic pain in adults. Generalized anxiety disorder (GAD) in adults. Adjunctive therapy in adults w/ partial seizures w/ or w/o secondary generalization. Management of fibromyalgia.
Dosage/Direction for Use
Neuropathic pain Initially 150 mg daily in 2 or 3 divided doses, may be increased to 300 mg daily after 3-7 days interval. Max: 600 mg daily after an additional 7-day interval. Epilepsy Initially 150 mg daily, may be increased to 300 mg daily after 1 wk. Max: 600 mg daily after an additional wk. GAD Initially 150 mg daily, may be increased to 300 mg daily after 1 wk, then to 450 mg daily following an additional wk. Max: 600 mg daily after an additional wk. Fibromyalgia 300-450 mg daily in 2 divided doses; begin at 75 mg bid & may be increased to 150 mg bid w/in 1 wk or may be further increased to 225 mg bid. Max: 600 mg daily after an additional wk. Renal impairment CrCl ≥60 mL/min Initially 150 mg daily bid or tid. Max dose: 600 mg daily, ≥30 to <60 mL/min Initially 75 mg daily bid or tid. Max dose: 300 mg daily, ≥15 to <30 mL/min 25-50 mg as single daily dose or bid. Max dose: 150 mg daily, <15 mL/min 25 mg as single daily dose. Max dose: 75 mg daily. Supplementary dose following haemodialysis Initially 25 mg daily as single dose. Max: 100 mg daily.
Administration
May be taken with or without food.
Contraindications
Special Precautions
Discontinue if symptoms of angioedema eg, facial, perioral or upper airway swelling occur. Peripheral edema; CV complications eg, HTN or CHF; dizziness & somnolence; loss of consciousness, confusion & mental impairment; wt gain; transient visual blurring & changes in visual acuity. Evaluate patients for history of drug abuse & signs of misuse or abuse or development of tolerance, dose escalation, drug-seeking behavior. Gradual discontinuation of treatment over min of 1 wk. Galactose intolerance, Lapp lactase deficiency or glucose-galactose malabsorption. Concomitant use w/ opioids. May affect ability to drive & use machines. Women of childbearing potential must use effective contraception. Not to be used during pregnancy. Not recommended during lactation. Not recommended in childn <12 yr & adolescents. Elderly >65 yr.
Adverse Reactions
Dizziness, somnolence. Nasopharyngitis; increased appetite; euphoric mood, confusion, irritability, depression, disorientation, insomnia, decreased libido; ataxia, abnormal coordination, tremor, dysarthria, amnesia, memory impairment, attention disturbance, paraesthesia, hypoesthesia, sedation, balance disorder, lethargy; blurred vision, diplopia; vertigo; vomiting, constipation, flatulence, abdominal distention, dry mouth; muscle cramp, arthralgia, back & limb pain, cervical spasm; peripheral oedema, oedema, abnormal gait, drunk or abnormal feeling, fatigue; increased wt. Headache; nausea, diarrhea.
Drug Interactions
Potentiated ethanol & lorazepam effects. Additive impairment of cognitive & gross motor function w/ oxycodone. Resp failure & coma w/ other CNS depressants. Reduced lower GI tract function w/ opioid analgesics.
MIMS Class
Anticonvulsants / Anxiolytics / Drugs for Neuropathic Pain
ATC Classification
N02BF02 - pregabalin ; Belongs to the class of gabapentinoids. Used to relieve pain and other conditions.
Presentation/Packing
Form
Lyrica hard cap 150 mg
Packing/Price
56's
Form
Lyrica hard cap 25 mg
Packing/Price
56's
Form
Lyrica hard cap 50 mg
Packing/Price
56's
Form
Lyrica hard cap 75 mg
Packing/Price
56's
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Already a member? Sign in
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Already a member? Sign in